Very Low Frequency Power of Heart Rate Variability is a Powerful Predictor of Clinical Prognosis in Patients with Congestive Heart Failure

Circulation Journal

Volumn 68, Issue 4, 2004, Pages 343-347

  Hadase, Mitsuyoshi ^a   Azuma, Akihiro ^a   Zen, Kan ^a   Asada, Satoshi ^b   Kawasaki, Tatsuya ^b   Kamitani, Tadaaki ^b   Kawasaki, Shingo ^b   Sugihara, Hiroki ^b   Matsubara, Hiroaki ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b MATSUSHITA MEMORIAL HOSPITAL   (Japan)

Author keywords

Congestive heart failure; Heart rate variability; Prognosis; Very low frequency power

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NORADRENALIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE EXACERBATION; EMERGENCY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE VARIABILITY; HOLTER MONITORING; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; RISK FACTOR;

AGED; AGED, 80 AND OVER; CHEYNE-STOKES RESPIRATION; COHORT STUDIES; COMORBIDITY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; LIFE TABLES; MALE; MIDDLE AGED; NOREPINEPHRINE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 1842732723     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.343     Document Type: Article

References (39)

1. Akselrod S, Gordon D, Ubel FA, Shanno DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science 1981; 213: 220-222.
2. Pagani M, Lombardi F, Guzzetti S, Rimoldi O, Furlan R, Pizzinelli P, et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympatho-vagal interaction in man and conscious dog. Circ Res 1986; 59: 178-193.
3. Abe Y, Tamura A, Nasu M. Relationship between heart rate variability and left ventricular remodeling after reperfused first anterior wall acute myocardial infarction. Circ J 2003; 67: 225-228.
4. Abe Y, Tamura A, Nasu M. Effect of preinfarction angina on heart rate variability in the early phase of the first anterior wall acute myocardial infarction. Circ J 2002; 66: 431-434.
5. Nakazawa K, Sakurai T, Takagi A, Kishi R, Osada K, Nanke T, et al. Autonomic imbalance as a property of symptomatic Brugada syndrome. Circ J 2003; 67: 511-514.
6. Li A, Kuga K, Suzuki A, Endo M, Niho B, Enomoto M, et al. Effects of linear ablation at the isthmus between the tricuspid annulus and inferior vena cava for atrial flutter on autonomic nervous activity: Analysis of heart rate variability. Circ J 2002; 66: 53-57.
7. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-823.
8. Packer M. Modulation of functional capacity and survival in congestive heart failure: Effects of activation of the sympathetic nervous system. Postgrad Med 1988; 83: 96-103.
9. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, et al. Prospective study of heart rate variability and mortality in chronic heart failure: Results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998; 98: 1510-1516.
10. Woo MA, Stevenson WG, Moser DK, Middlekauff HR. Complex heart rate variability and serum norepinephrine levels in patients with advanced heart failure. J Am Coll Cardiol 1994; 23: 565-569.
11. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993; 21: 729-736.
12. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992; 85: 164-171.
13. Huikuri HV, Koistinen MJ, Yli-Mayry S, Airaksinen KE, Seppanen T, Ikaheimo MJ, et al. Impaired low-frequency oscillations of heart rate in patients with prior acute myocardial infarction and life-threatening arrhythmias. Am J Cardiol 1995; 76: 56-60.
14. Albrecht P, Cohen RJ. Estimation of heart rate power spectrum bands from real-world data: Dealing with ectopic beats and noisy data. Comput Cardiol 1988; 15: 311-314.
15. Rottman JN, Steinman RC, Albrecht P, Bigger JT Jr, Rolnitzky LM, Fleiss JL. Efficient estimation of the heart period power spectrum suitable for physiologic or pharmacologic studies. Am J Cardiol 1990; 66: 1522-1524.
16. Koizumi K, Terui N, Kollai M. Effect of cardiac vagal and sympathetic nerve activity on heart rate in rhythmic regulations. J Auton Nerv Syst 1985; 12: 251-259.
17. Katona PG, Jih F. Respiratory sinus arrhythmia: Measure of the parasympathetic cardiac control. J Appl Physiol 1975; 39: 801-805.
18. Fouad FM, Tarazzi RC, Ferrario CM, Fighaly S, Alicandri C. Assessment of parasympathetic control of heart rate by a noninvasive method. Am J Physiol 1984; 246: H838-H842.
19. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: Advantages of a new specific activity scale. Circulation 1981; 64: 1227-1234.
20. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36: 2138-2147.
21. Yandle TG, Richards AM, Gilbert A, Fisher S, Holmes S, Espiner EA. Assay of brain natriuretic peptide (BNP) in human plasma: Evidence for high molecular weight bnp as a major plasma component in heart failure. J Clin Endocrinol Metab 1993; 76: 832-838.
22. Goldstein DS, Feuerstein G, Izzo JL Jr, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981; 28: 467-475.
23. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990; 82: 1724-1729.
24. Ferguson DW, Berg WJ, Roach PJ, Oren RM, Mark AL. Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol 1992; 69: 523-531.
25. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity in patients with chronic heart failure. N Engl J Med 1996; 3334: 1349-1355.
26. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-533.
27. Dougherty AH, Naccarelli GV, Gray EL, Hicks CH, Goldstein RA. Congestive heart failure with normal systolic function. Am J Cardiol 1984; 54: 778-782.
28. Soufer R, Wohlgelernter D, Vita NA, Amuchestegui M, Sostman HD, Berger HJ, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1985; 55: 1032-1036.
29. Grantham JA, Borgeson DD, Burnett JC Jr. BNP: Pathophysiological and potential therapeutic roles in acute congestive heart failure. Am J Physiol 1997; 272: R1077-R1083.
30. Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994; 235: 561-576.
31. Tsutamoto T, Wada A, Maeda K, Hisinaga T, Maeda Y, Fukai D, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997; 96: 509-516.
32. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002; 105: 2392-2397.
33. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, et al. Utility of b-natriuretic peptide in detecting diastolic dysfunction: Comparison with doppler velocity recordings. Circulation 2002; 105: 595-601.
34. Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Rrespir Crit Care Med 1995; 152: 473-479.
35. Lanfranchi PA, Braghiroli A, Bosimini E, Mazzuero G, Colombo R, Donner CF, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99: 1435-1440.
36. Mortara A, Sleight P, Pinna GD, Maestri R, Prpa A, La Rouvere MT, et al. Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability. Circulation 1997; 96: 246-252.
37. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 1991; 84: 482-492.
38. Parati G, Saul JP, Di Rieuzo M, Mancia G. Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: A critical appraisal. Hypertension 1995; 25: 1276-1286.
39. Bernadi L, Valle F, Coco M, Calciati A, Sleight P. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res 1996; 32: 234-237.